AIM-HI Accelerator Fund Honors Anna D. Barker, Ph.D., with Inaugural Beacon Award for Women Leaders in Oncology
ROCKVILLE, MD – The AIM-HI Accelerator Fund (AIM-HI) today announced the recipient of its inaugural…
The AIM-HI Accelerator Fund (AIM-HI), together with our partner organizations, the National Foundation for Cancer Research and the Asian Fund for Cancer Research, successfully concluded the 2022 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October 22, in person and live-streamed at the National Press Club in Washington DC.
We encourage you to visit our Oncology Metaverse to hear the speeches and discussions from key opinion leaders in basic and clinical research, including scientists, clinicians, biotech executives, entrepreneurs, investors, cancer patients, advocates, and leaders from the U.S. National Cancer Institute:
I was very impressed by everything I heard. I found the presented research to be of really high-quality and very innovative. This is very refreshing, and, in my opinion, sets AIM-HI and NFCR apart in a very good way.”
– Isidore Rigoutsos, Ph.D., Richard W. Hevner Professor of Professor in Computational Medicine, Director of Computational Medicine Center, Thomas Jefferson University
This Global Summit showcased a community we are building, a community critically needed to move the needle for innovative cancer research and oncology start-ups working on the next generations of new therapies and technologies for cancer patients.
Please consider joining the community we are building to accelerate cancer discoveries from the lab to the clinics. Become a member of our community to help support scientist-entrepreneurs who are creating life-saving oncology innovations!